Insights

Strategic Acquisition Cubist’s acquisition of TriusRX for 700M signals a growth-by-acquisition strategy and a willingness to scale capabilities quickly, presenting opportunities for sales partnerships around post-acquisition integration services, analytics, and operational support.

Subsidiary of Merck As of January 2015 Cubist operates as a wholly owned subsidiary of Merck, suggesting limited direct autonomy but potential collaboration channels through Merck’s corporate procurement, IT, and external partnerships for technology, manufacturing enhancements, and supplier rationalization.

Mid-Sized Scale With 51-200 employees and revenue in the sub-billion range, Cubist represents a mid-sized pharma player that commonly seeks cost-effective manufacturing improvements, niche biopharma capabilities, and focused contract services to accelerate development without large enterprise engagement overheads.

M&A Footprint A history of acquisitions indicates a receptivity to scalable solutions that integrate with diverse portfolios; sales opportunities exist in due diligence support, integration software, regulatory and quality systems, and post-merger harmonization services.

Competitive Positioning Operating in the pharmaceutical manufacturing space with peers that include large, well-funded firms, Cubist may value cost optimization, supply chain resilience, and compliance enhancements; offering lean manufacturing technologies, GMP optimization, and risk management solutions could address strategic gaps.

Similar companies to Cubist Pharmaceuticals

Cubist Pharmaceuticals's Email Address Formats

Cubist Pharmaceuticals uses at least 4 email formats:
Cubist Pharmaceuticals Email FormatsExamplePercentage
First.Last@cubist.comJohn.Doe@cubist.com
85%
FLast@cubist.comJDoe@cubist.com
8%
First.L@cubist.comJohn.D@cubist.com
4%
First_Last@cubist.comJohn_Doe@cubist.com
3%

Frequently Asked Questions

What is Cubist Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Cubist Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cubist Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Cubist Pharmaceuticals is a publicly traded company; the company's stock symbol is CBST.

What is Cubist Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Cubist Pharmaceuticals's official website is cubist.com and has social profiles on LinkedIn.

How much revenue does Cubist Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2026, Cubist Pharmaceuticals's annual revenue is estimated to be $250M - $500M.

What is Cubist Pharmaceuticals's SIC code and NAICS code?

Minus sign iconPlus sign icon
Cubist Pharmaceuticals's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cubist Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2026, Cubist Pharmaceuticals has approximately 183 employees across 6 continents, including North America, Asia and Europe. Key team members include Chief Executive Officer: J. M., Chief Commercial Officer, Sgd: T. K. and Vice President: C. L. Explore Cubist Pharmaceuticals's employee directory with LeadIQ.

What industry does Cubist Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Cubist Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What is Cubist Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Cubist Pharmaceuticals's email format typically follows the pattern of First.Last@cubist.com. Find more Cubist Pharmaceuticals email formats with LeadIQ.

When was Cubist Pharmaceuticals founded?

Minus sign iconPlus sign icon
Cubist Pharmaceuticals was founded in 1992.
Cubist Pharmaceuticals logo

Cubist Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

Cubist Pharmaceuticals is a pharmaceutical manufacturing company based at 65 Hayden Avenue, Lexington, Massachusetts 02421, United States, and employs 51-200 people. It operates in the pharmaceutical industry and maintains a corporate website at cubist.com. Effective January 22, 2015, Cubist became a wholly owned subsidiary of Merck & Co., Inc. In January 2021, Cubist announced the acquisition of Triusrx for $700 million. A December 19, 2018 report states Merck acquired Cubist for $9.5 billion on January 1, 2015.

Section iconCompany Overview

Phone number
Website
cubist.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CBST
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1992
Employees
51-200

Section iconFunding & Financials

  • $250M - $500M

    Cubist Pharmaceuticals's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.